Research Progress for Targeting Deubiquitinases in Gastric Cancers

Gastric cancers (GCs) are malignant tumors with a high incidence that threaten global public health. Despite advances in GC diagnosis and treatment, the prognosis remains poor. Therefore, the mechanisms underlying GC progression need to be identified to develop prognostic biomarkers and therapeutic...

Full description

Bibliographic Details
Main Authors: Tao An, Yanting Lu, Zhaoqi Gong, Yongtao Wang, Chen Su, Guimei Tang, Jingjing Hou
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/23/5831
_version_ 1797463550983143424
author Tao An
Yanting Lu
Zhaoqi Gong
Yongtao Wang
Chen Su
Guimei Tang
Jingjing Hou
author_facet Tao An
Yanting Lu
Zhaoqi Gong
Yongtao Wang
Chen Su
Guimei Tang
Jingjing Hou
author_sort Tao An
collection DOAJ
description Gastric cancers (GCs) are malignant tumors with a high incidence that threaten global public health. Despite advances in GC diagnosis and treatment, the prognosis remains poor. Therefore, the mechanisms underlying GC progression need to be identified to develop prognostic biomarkers and therapeutic targets. Ubiquitination, a post-translational modification that regulates the stability, activity, localization, and interactions of target proteins, can be reversed by deubiquitinases (DUBs), which can remove ubiquitin monomers or polymers from modified proteins. The dysfunction of DUBs has been closely linked to tumorigenesis in various cancer types, and targeting certain DUBs may provide a potential option for cancer therapy. Multiple DUBs have been demonstrated to function as oncogenes or tumor suppressors in GC. In this review, we summarize the DUBs involved in GC and their associated upstream regulation and downstream mechanisms and present the benefits of targeting DUBs for GC treatment, which could provide new insights for GC diagnosis and therapy.
first_indexed 2024-03-09T17:52:19Z
format Article
id doaj.art-71da0ed53e89454383f1d41f973eeb39
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T17:52:19Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-71da0ed53e89454383f1d41f973eeb392023-11-24T10:39:23ZengMDPI AGCancers2072-66942022-11-011423583110.3390/cancers14235831Research Progress for Targeting Deubiquitinases in Gastric CancersTao An0Yanting Lu1Zhaoqi Gong2Yongtao Wang3Chen Su4Guimei Tang5Jingjing Hou6School of Pharmaceutical Sciences, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250353, ChinaSchool of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, ChinaSchool of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, ChinaDepartment of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, ChinaSchool of Pharmaceutical Sciences, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, ChinaDepartment of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, ChinaGastric cancers (GCs) are malignant tumors with a high incidence that threaten global public health. Despite advances in GC diagnosis and treatment, the prognosis remains poor. Therefore, the mechanisms underlying GC progression need to be identified to develop prognostic biomarkers and therapeutic targets. Ubiquitination, a post-translational modification that regulates the stability, activity, localization, and interactions of target proteins, can be reversed by deubiquitinases (DUBs), which can remove ubiquitin monomers or polymers from modified proteins. The dysfunction of DUBs has been closely linked to tumorigenesis in various cancer types, and targeting certain DUBs may provide a potential option for cancer therapy. Multiple DUBs have been demonstrated to function as oncogenes or tumor suppressors in GC. In this review, we summarize the DUBs involved in GC and their associated upstream regulation and downstream mechanisms and present the benefits of targeting DUBs for GC treatment, which could provide new insights for GC diagnosis and therapy.https://www.mdpi.com/2072-6694/14/23/5831gastric cancerdeubiquitinasesbiomarkerstumorigenesispathogenesisdiagnosis
spellingShingle Tao An
Yanting Lu
Zhaoqi Gong
Yongtao Wang
Chen Su
Guimei Tang
Jingjing Hou
Research Progress for Targeting Deubiquitinases in Gastric Cancers
Cancers
gastric cancer
deubiquitinases
biomarkers
tumorigenesis
pathogenesis
diagnosis
title Research Progress for Targeting Deubiquitinases in Gastric Cancers
title_full Research Progress for Targeting Deubiquitinases in Gastric Cancers
title_fullStr Research Progress for Targeting Deubiquitinases in Gastric Cancers
title_full_unstemmed Research Progress for Targeting Deubiquitinases in Gastric Cancers
title_short Research Progress for Targeting Deubiquitinases in Gastric Cancers
title_sort research progress for targeting deubiquitinases in gastric cancers
topic gastric cancer
deubiquitinases
biomarkers
tumorigenesis
pathogenesis
diagnosis
url https://www.mdpi.com/2072-6694/14/23/5831
work_keys_str_mv AT taoan researchprogressfortargetingdeubiquitinasesingastriccancers
AT yantinglu researchprogressfortargetingdeubiquitinasesingastriccancers
AT zhaoqigong researchprogressfortargetingdeubiquitinasesingastriccancers
AT yongtaowang researchprogressfortargetingdeubiquitinasesingastriccancers
AT chensu researchprogressfortargetingdeubiquitinasesingastriccancers
AT guimeitang researchprogressfortargetingdeubiquitinasesingastriccancers
AT jingjinghou researchprogressfortargetingdeubiquitinasesingastriccancers